NYSE:CORHealthcare
How Cencora’s Valuation Re‑Rating At Cencora (COR) Has Changed Its Investment Story
Recent stock screens have brought past moves in Cencora into focus, highlighting rising P/E ratios, strong multi‑year returns, and its shares trading at a discount to several intrinsic value and market‑based estimates.
This renewed attention on Cencora’s valuation metrics has shifted investor sentiment, as the company now screens as potentially undervalued despite its long‑term gains.
With Cencora now screening as potentially undervalued on several models, we’ll examine how this renewed...